Organisms
This organism has 903 curated pathways:
Human pathways
This page lists all pathways relevant to Human.
Download pathways by species in any of the following formats: GPML, GMT or SVG.
Table FiltersThis organism has 903 curated pathways:
- 10q11.21q11.23 copy number variation syndrome - WP5352
- 10q22q23 copy number variation - WP5402
- 11p11.2 copy number variation syndrome - WP5348
- 13q12 or CRYL1 copy number variation - WP5405
- 13q12.12 copy number variation - WP5406
- 15q11.2 copy number variation syndrome - WP4940
- 15q11q13 copy number variation - WP5407
- 15q13.3 copy number variation syndrome - WP4942
- 15q25 copy number variation - WP5408
- 16p11.2 distal deletion syndrome - WP4950
- 16p11.2 proximal deletion syndrome - WP4949
- 17p13.3 (YWHAE) copy number variation - WP5376
- 17q12 copy number variation syndrome - WP5287
- 1p36 copy number variation syndrome - WP5345
- 1q21.1 copy number variation syndrome - WP4905
- 22q11.2 copy number variation syndrome - WP4657
- 2q11.2 copy number variation syndrome - WP5221
- 2q13 copy number variation syndrome - WP5222
- 2q21.1 copy number variation syndrome - WP5223
- 2q37 copy number variation syndrome - WP5224
- 3q29 copy number variation syndrome - WP4906
- 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression - WP3879
- 4p16.3 copy number variation - WP5365
- 5q35 copy number variation - WP5380
- 6q16 copy number variation - WP5400
- 7-oxo-C and 7-beta-HC pathways - WP5064
- 7q11.23 copy number variation syndrome - WP4932
- 7q11.23 distal copy number variation - WP5401
- 8p23.1 copy number variation syndrome - WP5346
- 8q11.23 (RB1CC1) copy number variation - WP5412
- ACE inhibitor pathway - WP554
- ACE2 inhibition leads to pulmonary fibrosis - WP5035
- ADHD and autism (ASD) pathways - WP5420
- AGE/RAGE pathway - WP2324
- ALA oxylipin metabolism - WP5136
- AMP-activated protein kinase signaling - WP1403
- ATM signaling in development and disease - WP3878
- ATM signaling pathway - WP2516
- ATR signaling - WP3875
- Abnormal calcium handling and its effects on muscle contraction in DMD - WP5343
- Acetaminophen in analgesia and antipyresis - WP5444
- Acetylcholine synthesis - WP528
- Acquired partial lipodystrophy / Barraquer-Simons syndrome - WP5104
- Acrylamide biotransformation and exposure biomarkers - WP4233
- Activation of NLRP3 inflammasome by SARS-CoV-2 - WP4876
- Acute myeloid leukemia - WP5293
- Acute viral myocarditis - WP4298
- Adipogenesis - WP236
- Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition - WP4914
- Aerobic glycolysis - WP4629
- Aerobic glycolysis - augmented - WP4628
- Affected pathways in Duchenne muscular dystrophy - WP5356
- Aflatoxin B1 metabolism - WP699
- Airway smooth muscle cell contraction - WP4962
- Alanine and aspartate metabolism - WP106
- Allograft rejection - WP2328
- Alpha 6 beta 4 signaling pathway - WP244
- Alstrom syndrome - WP5202
- Altered glycosylation of MUC1 in tumor microenvironment - WP4480
- Alternative pathway of fetal androgen synthesis - WP4524
- Alzheimer's disease - WP5124
- Alzheimer's disease and miRNA effects - WP2059
- Amino acid conjugation - WP715
- Amino acid conjugation of benzoic acid - WP521
- Amino acid metabolism - WP3925
- Amino acid metabolism in triple-negative breast cancer cells - WP5213
- Amino acid metabolism pathway excerpt: histidine catabolism extension - WP4661
- Amino acid transport defects (IEMs) - WP5029
- Amplification and expansion of oncogenic pathways as metastatic traits - WP3678
- Amyotrophic lateral sclerosis (ALS) - WP2447
- Androgen receptor network in prostate cancer - WP2263
- Androgen receptor signaling pathway - WP138
- Angiogenesis - WP1539
- Angiopoietin-like protein 8 regulatory pathway - WP3915
- Angiotensin II receptor type 1 pathway - WP5036
- Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway - WP5113
- ApoE and miR-146 in inflammation and atherosclerosis - WP3926
- Apoptosis - WP254
- Apoptosis modulation and signaling - WP1772
- Apoptosis modulation by HSP70 - WP384
- Apoptosis-related network due to altered Notch3 in ovarian cancer - WP2864
- Arachidonate epoxygenase / epoxide hydrolase - WP678
- Arachidonic acid (AA, ARA) oxylipin metabolism - WP5155
- Aripiprazole metabolic pathway - WP2640
- Arrhythmogenic right ventricular cardiomyopathy - WP2118
- Arsenic liver toxicity pathway - WP5228
- Arsenic metabolism and reactive oxygen species generation - WP5233
- Artemisinin inhibition of uveal melanoma - WP5441
- Aryl hydrocarbon receptor pathway - WP2586
- Aryl hydrocarbon receptor pathway - WP2873
- Arylamine metabolism - WP694
- Aspirin and miRNAs - WP4707
- Autophagy - WP4923
- Autophagy in pancreatic ductal adenocarcinoma - WP5331
- Autosomal recessive osteopetrosis pathways - WP4788
- B cell receptor signaling pathway - WP23
- BDNF-TrkB signaling - WP3676
- BMP signaling in eyelid development - WP3927
- BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation - WP3876
- Bardet-Biedl syndrome - WP5234
- Base excision repair - WP4752
- Benzene metabolism - WP3891
- Benzo(a)pyrene metabolism - WP696
- Bile acids synthesis and enterohepatic circulation - WP4389
- Biochemical pathways: part I - WP3604
- Biogenic amine synthesis - WP550
- Biomarkers for pyrimidine metabolism disorders - WP4584
- Biomarkers for urea cycle disorders - WP4583
- Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine - WP4156
- Biosynthesis and turnover of 1-deoxy-sphingoid bases - WP5179
- Biotin metabolism, including IMDs - WP5031
- Bladder cancer - WP2828
- Blood clotting and drug effects - WP4580
- Blood clotting cascade - WP272
- Bone morphogenic protein signaling and regulation - WP1425
- Brain-derived neurotrophic factor (BDNF) signaling pathway - WP2380
- Breast cancer pathway - WP4262
- Burn wound healing - WP5055
- Butyrate-induced histone acetylation - WP2366
- CAMKK2 pathway - WP4874
- CCL18 signaling pathway - WP5097
- COVID-19 adverse outcome pathway - WP4891
- COVID-19 and endothelial cell senescence - WP5256
- COVID-19 structural coverage map - WP5145
- COVID-19, thrombosis and anticoagulation - WP4927
- Caffeine and theobromine metabolism - WP3633
- Calcium mediated T-cell apoptosis involved in inclusion body myositis - WP5142
- Calcium regulation in cardiac cells - WP536
- Caloric restriction and aging - WP4191
- Cancer immunotherapy by CTLA4 blockade - WP4582
- Cancer immunotherapy by PD-1 blockade - WP4585
- Cancer pathways - WP5434
- Cannabinoid receptor signaling - WP3869
- Canonical NF-kB pathway - WP4562
- Canonical and non-canonical Notch signaling - WP3845
- Canonical and non-canonical TGF-B signaling - WP3874
- Cardiac hypertrophic response - WP2795
- Cardiac progenitor differentiation - WP2406
- Cardiomyocyte signaling pathways converging on titin - WP5344
- Carnosine metabolism of glial cells - WP5313
- Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs) - WP688
- Cell cycle - WP179
- Cell differentiation - expanded index - WP2023
- Cell differentiation - index - WP2029
- Cell interactions of the pancreatic cancer microenvironment - WP5284
- Cell lineage map for neuronal differentiation - WP5417
- Cell-type dependent selectivity of CCK2R signaling - WP3679
- Cells and molecules involved in local acute inflammatory response - WP4493
- Cellular proteostasis - WP4918
- Cerebral organic acidurias, including diseases - WP4519
- Chemokine signaling pathway - WP3929
- Cholestasis - WP5238
- Cholesterol biosynthesis pathway - WP197
- Cholesterol biosynthesis pathway in hepatocytes - WP5329
- Cholesterol biosynthesis with skeletal dysplasias - WP4804
- Cholesterol metabolism - WP5304
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4718
- Cholesterol synthesis disorders - WP5193
- Chromosomal and microsatellite instability in colorectal cancer - WP4216
- Chronic hyperglycemia impairment of neuron function - WP5283
- Ciliary landscape - WP4352
- Ciliopathies - WP4803
- Circadian rhythm genes - WP3594
- Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism - WP4523
- Clear cell renal cell carcinoma pathways - WP4018
- Clock-controlled autophagy in bone metabolism - WP5205
- Cocaine metabolism - WP2826
- Codeine and morphine metabolism - WP1604
- Cohesin complex - Cornelia de Lange syndrome - WP5117
- Colchicine metabolic pathway - WP2536
- Common pathways underlying drug addiction - WP2636
- Complement activation - WP545
- Complement and coagulation cascades - WP558
- Complement system - WP2806
- Complement system in neuronal development and plasticity - WP5090
- Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway) - WP5148
- Congenital generalized lipodystrophy - WP5101
- Constitutive androstane receptor pathway - WP2875
- Control of immune tolerance by vasoactive intestinal peptide - WP4484
- Conversion of angiotensinogen to angiotensin II - WP4818
- Copper homeostasis - WP3286
- Copper metabolism - WP5189
- Cori cycle - WP1946
- Corticotropin-releasing hormone signaling pathway - WP2355
- Creatine pathway - WP5190
- Cysteine and methionine catabolism - WP4504
- Cytokines and inflammatory response - WP530
- Cytoplasmic ribosomal proteins - WP477
- Cytosine methylation - WP3585
- Cytosolic DNA-sensing pathway - WP4655
- DDX1 as a regulatory component of the Drosha microprocessor - WP2942
- DNA IR-damage and cellular response via ATR - WP4016
- DNA IR-double strand breaks and cellular response via ATM - WP3959
- DNA adduct formation leading to kidney failure - WP5389
- DNA damage response - WP707
- DNA damage response (only ATM dependent) - WP710
- DNA mismatch repair - WP531
- DNA repair pathways, full network - WP4946
- DNA replication - WP466
- DYRK1A involvement regarding cell proliferation in brain development - WP5180
- Degradation pathway of sphingolipids, including diseases - WP4153
- Dengue-2 interactions with complement and coagulation cascades - WP3896
- Deregulation of Rab and Rab effector genes in bladder cancer - WP2291
- Development and heterogeneity of the ILC family - WP3893
- Development of pulmonary dendritic cells and macrophage subsets - WP3892
- Development of ureteric collection system - WP5053
- Diclofenac metabolic pathway - WP2491
- Diet-dependent trimethylamine/trimethylamine N-oxide metabolism - WP5219
- Differentiation of white and brown adipocyte - WP2895
- Direct reversal repair - WP4931
- Disorders in ketolysis - WP5195
- Disorders in ketone body synthesis - WP5175
- Disorders of bile acid synthesis and biliary transport - WP5176
- Disorders of folate metabolism and transport - WP4259
- Disorders of fructose metabolism - WP5178
- Disorders of galactose metabolism - WP5173
- Disruption of postsynaptic signaling by CNV - WP4875
- Docosahexaenoic acid oxylipin metabolism - WP5154
- Dopamine metabolism - WP2436
- Dopaminergic neurogenesis - WP2855
- Downregulation of ACE2 by SARS-CoV-2 spike protein - WP4799
- Dravet syndrome - WP5200
- Drug induction of bile acid pathway - WP2289
- Dual hijack model of Vif in HIV infection - WP3300
- EDA signaling in hair follicle development - WP3930
- EGF/EGFR signaling pathway - WP437
- EGFR tyrosine kinase inhibitor resistance - WP4806
- EPAC1 and PKA reduction of retinal inflammation - WP5440
- EPO receptor signaling - WP581
- ERK pathway in Huntington's disease - WP3853
- EV release from cardiac cells and their functional effects - WP3297
- Ebola virus infection in host - WP4217
- Ebstein-Barr virus LMP1 signaling - WP262
- Ectoderm differentiation - WP2858
- Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists - WP5273
- Effect of progerin on genes involved in progeria - WP4320
- Effects of MFN2 mutation - WP5443
- Effects of nitric oxide - WP1995
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4719
- Eicosanoid metabolism via cytochrome P450 monooxygenases pathway - WP4720
- Eicosanoid metabolism via lipooxygenases (LOX) - WP4721
- Eicosanoid synthesis - WP167
- Electron transport chain: OXPHOS system in mitochondria - WP111
- Embryonic stem cell pluripotency pathways - WP3931
- Endochondral ossification - WP474
- Endochondral ossification with skeletal dysplasias - WP4808
- Endoderm differentiation - WP2853
- Endometrial cancer - WP4155
- Endoplasmic reticulum stress response in coronavirus infection - WP4861
- Endothelin pathways - WP2197
- Energy metabolism - WP1541
- Enterocyte cholesterol metabolism - WP5333
- Enterohepatic circulation of bile acids - WP5396
- Envelope proteins and their potential roles in EDMD physiopathology - WP4535
- Epithelial to mesenchymal transition in colorectal cancer - WP4239
- ErbB signaling pathway - WP673
- Estradiol regulation in porto-sinusoidal vascular disease - WP5235
- Estrogen metabolism - WP5276
- Estrogen metabolism - WP697
- Estrogen receptor pathway - WP2881
- Estrogen signaling pathway - WP712
- Ethanol effects on histone modifications - WP3996
- Ethanol metabolism production of ROS by CYP2E1 - WP4269
- Ether lipid biosynthesis - WP5275
- Ethylmalonic encephalopathy - WP5030
- Eukaryotic transcription initiation - WP405
- Evolocumab mechanism to reduce LDL cholesterol - WP3408
- Exercise-induced circadian regulation - WP410
- Extracellular vesicle-mediated signaling in recipient cells - WP2870
- Extracellular vesicles in the crosstalk of cardiac cells - WP4300
- Extrafollicular and follicular B cell activation by SARS-CoV-2 - WP5218
- FABP4 in ovarian cancer - WP4400
- FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma - WP4553
- FGF23 signaling in hypophosphatemic rickets and related disorders - WP4790
- FGFR3 signaling in chondrocyte proliferation and terminal differentiation - WP4767
- FGFR4 p.G388R signaling pathway - WP5428
- FLT3 p.Gln640SerfsTer8 signaling pathway - WP5431
- FOXA2 pathway - WP5066
- FOXP3 in COVID-19 - WP5063
- FTO obesity variant mechanism - WP3407
- Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling - WP3850
- Familial hyperlipidemia type 1 - WP5108
- Familial hyperlipidemia type 2 - WP5109
- Familial hyperlipidemia type 3 - WP5110
- Familial hyperlipidemia type 4 - WP5111
- Familial hyperlipidemia type 5 - WP5112
- Familial partial lipodystrophy - WP5102
- Farnesoid X receptor pathway - WP2879
- Farnesyl to CoQ10 metabolism - WP5274
- Fas ligand pathway and stress induction of heat shock proteins - WP314
- Fatty acid beta-oxidation - WP143
- Fatty acid biosynthesis - WP357
- Fatty acid omega-oxidation - WP206
- Fatty acid transporters - WP5061
- Fatty acids and lipoproteins transport in hepatocytes - WP5323
- Felbamate metabolism - WP2816
- Female steroid hormones in cardiomyocyte energy metabolism - WP5318
- Ferroptosis - WP4313
- Fibrin complement receptor 3 signaling pathway - WP4136
- Flavan-3-ol metabolic pathway - WP4238
- Fluoroacetic acid toxicity - WP4966
- Fluoropyrimidine activity - WP1601
- Focal adhesion - WP306
- Focal adhesion: PI3K-Akt-mTOR-signaling pathway - WP3932
- Folate metabolism - WP176
- Folate-alcohol and cancer pathway hypotheses - WP1589
- Follicle stimulating hormone (FSH) signaling pathway - WP2035
- Fragile X syndrome - WP4549
- Frustrated phagocytosis leading to malignant pleural mesothelioma - WP5091
- G protein signaling pathways - WP35
- G1 to S cell cycle control - WP45
- G13 signaling pathway - WP524
- GABA metabolism (aka GHB) - WP4157
- GABA receptor signaling - WP4159
- GDNF signaling - WP5143
- GDNF/RET signaling axis - WP4830
- GLP-1 from intestine and pancreas and role in glucose homeostasis - WP5452
- GLP-1 in pancreatic islet cells - WP5447
- GLP-1 secretion from intestine to portal vein - WP5446
- GNAQ pathways in port-wine stain - WP5437
- GPCRs, class A rhodopsin-like - WP455
- GPCRs, class B secretin-like - WP334
- GPCRs, class C metabotropic glutamate, pheromone - WP501
- GPCRs, other - WP117
- GPR143 in melanocytes and retinal pigment epithelium cells - WP4941
- GPR40 pathway - WP3958
- Galanin receptor pathway - WP4970
- Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases - WP4518
- Ganglio series sphingolipid metabolism - WP5299
- Ganglio sphingolipid metabolism - WP1423
- Gastric acid production - WP2596
- Gastric cancer network 1 - WP2361
- Gastric cancer network 2 - WP2363
- Gastrin signaling pathway - WP4659
- Gene regulatory network modeling somitogenesis - WP2854
- Genes associated with the development of rheumatoid arthritis - WP5033
- Genes controlling nephrogenesis - WP4823
- Genes related to primary cilium development (based on CRISPR) - WP4536
- Genes targeted by miRNAs in adipocytes - WP1992
- Genetic causes of porto-sinusoidal vascular disease - WP5269
- Glial cell differentiation - WP2276
- Glioblastoma signaling pathways - WP2261
- Glucocorticoid biosynthesis - WP5280
- Glucocorticoid receptor pathway - WP2880
- Glucose homeostasis - WP661
- Glucose metabolism in triple-negative breast cancer cells - WP5211
- Glucuronidation - WP698
- Glutathione metabolism - WP100
- Glycerolipids and glycerophospholipids - WP4722
- Glycerophospholipid biosynthetic pathway - WP2533
- Glycine metabolism - WP1495
- Glycine metabolism, including IMDs - WP5028
- Glycogen synthesis and degradation - WP500
- Glycolysis and gluconeogenesis - WP534
- Glycolysis in senescence - WP5049
- Glycosaminoglycan degradation - WP4815
- Glycosaminoglycan synthesis in fibroblasts - WP5395
- Glycosphingolipid metabolism - WP5292
- Glycosylation and related congenital defects - WP4521
- Glyoxylate metabolism - WP5166
- Growth factors and hormones in beta cell proliferation - WP5385
- Gut-liver indole metabolism - WP3627
- H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity - WP3969
- HDAC6 interactions in the central nervous system - WP5426
- HIF1A and PPARG regulation of glycolysis - WP2456
- HIPK2 in kidney fibrosis - WP4751
- Hair follicle development: cytodifferentiation - part 3 of 3 - WP2840
- Hair follicle development: organogenesis - part 2 of 3 - WP2839
- Head and neck squamous cell carcinoma - WP4674
- Heart development - WP1591
- Hedgehog signaling pathway - WP4249
- Hedgehog signaling pathway - WP47
- Hematopoietic stem cell differentiation - WP2849
- Hematopoietic stem cell gene regulation by GABP alpha/beta complex - WP3657
- Heme biosynthesis - WP561
- Hemesynthesis defects and porphyrias - WP5169
- Hepatitis B infection - WP4666
- Hepatitis C and hepatocellular carcinoma - WP3646
- Hepatocyte growth factor receptor signaling - WP313
- Hereditary leiomyomatosis and renal cell carcinoma pathway - WP4206
- Heroin metabolism - WP2645
- Hfe effect on hepcidin production - WP3924
- Hijack of ubiquitination by SARS-CoV-2 - WP4860
- Hippo signaling regulation pathways - WP4540
- Hippo-Merlin signaling dysregulation - WP4541
- Hippo-YAP signaling - WP4537
- Hippocampal synaptogenesis and neurogenesis - WP5231
- Histone modifications - WP2369
- Homologous recombination - WP186
- Hormonal control of pubertal growth spurt - WP4194
- Host-pathogen interaction of human coronaviruses - MAPK signaling - WP4877
- Host-pathogen interaction of human coronaviruses - apoptosis - WP4864
- Host-pathogen interaction of human coronaviruses - autophagy - WP4863
- Host-pathogen interaction of human coronaviruses - interferon induction - WP4880
- Hunger and satiety - WP5445
- Hypertrophy model - WP516
- Hypothesized pathways in pathogenesis of cardiovascular disease - WP3668
- Hypothetical craniofacial development pathway - WP3655
- Hypoxia-mediated EMT and stemness - WP2943
- ID signaling pathway - WP53
- IDO metabolic pathway - WP5414
- IL-1 signaling pathway - WP195
- IL-10 anti-inflammatory signaling pathway - WP4495
- IL-17 signaling pathway - WP2112
- IL-18 signaling pathway - WP4754
- IL-19 signaling pathway - WP5422
- IL-2 signaling pathway - WP49
- IL-26 signaling pathways - WP5347
- IL-3 signaling pathway - WP286
- IL-4 signaling pathway - WP395
- IL-5 signaling pathway - WP127
- IL-7 signaling pathway - WP205
- IL-9 signaling pathway - WP22
- IL1 and megakaryocytes in obesity - WP2865
- IL6 signaling pathway - WP364
- Imatinib and chronic myeloid leukemia - WP3640
- Immune infiltration in pancreatic cancer - WP5285
- Immune response to tuberculosis - WP4197
- Inclusion body myositis - WP5120
- Induction of autophagy and toll-like receptor signaling pathways by graphene oxide - WP5336
- Inflammatory bowel disease signaling - WP5198
- Inflammatory response pathway - WP453
- Influence of laminopathies on Wnt signaling - WP4844
- Influenza A virus infection - WP1438
- Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells - WP4301
- Initiation of transcription and translation elongation at the HIV-1 LTR - WP3414
- Insulin signaling - WP481
- Insulin signaling in adipocytes (diabetic condition) - WP3635
- Insulin signaling in adipocytes (normal condition) - WP3634
- Integrated cancer pathway - WP1971
- Integrin-mediated cell adhesion - WP185
- Interactions between LOXL4 and oxidative stress pathway - WP3670
- Interactions between immune cells and microRNAs in tumor microenvironment - WP4559
- Interactions of natural killer cells in pancreatic cancer - WP5092
- Interactome of polycomb repressive complex 2 (PRC2) - WP2916
- Interferon type I signaling pathways - WP585
- Interleukin-1 (IL-1) structural pathway - WP2637
- Interleukin-1 induced activation of NF-kB - WP3656
- Interleukin-11 signaling pathway - WP2332
- Intracellular trafficking proteins involved in CMT neuropathy - WP4856
- Intraflagellar transport proteins binding to dynein - WP4532
- Involvement of δ-secretase in neurodegenerative diseases - WP5372
- Irinotecan pathway - WP229
- Iron metabolism disorders - WP5172
- Iron metabolism in placenta - WP2007
- Iron-sulfur cluster biogenesis - WP5152
- Isoglobo series sphingolipids - WP5311
- JAK-STAT signaling in the regulation of beta cells - WP5358
- Joubert syndrome - WP4656
- KCNQ2-related epilepsies - WP5360
- Kallmann syndrome - WP5074
- Kennedy pathway from sphingolipids - WP3933
- Ketogenesis and ketolysis - WP4742
- Kinin-Kallikrein pathway - WP5089
- Kisspeptin/kisspeptin receptor system in the ovary - WP4871
- Kit receptor signaling pathway - WP304
- Kleefstra syndrome - WP5351
- Krebs cycle disorders - WP4236
- Kynurenine pathway and links to cell senescence - WP5044
- LDL- influence on CD14 and TLR4 - WP5272
- LDLRAD4 and what we know about it - WP4904
- LTF danger signal response pathway - WP4478
- Lac-Phe pathway - WP5239
- Lactate shuttle in glial cells - WP5314
- Lacto series sphingolipid metabolism - WP5303
- Lamin A processing pathway - WP4299
- Leptin and adiponectin - WP3934
- Leptin signaling pathway - WP2034
- Leptin-insulin signaling overlap - WP3935
- Leucine, isoleucine and valine metabolism - WP4686
- Leukocyte-intrinsic Hippo pathway functions - WP4542
- Leukotriene metabolic pathway - WP5171
- Lidocaine metabolism - WP2646
- Linoleic acid metabolism affected by SARS-CoV-2 - WP4853
- Linoleic acid oxylipin metabolism - WP5137
- Lipid metabolism in senescent cells - WP5149
- Lipid metabolism pathway - WP3965
- Lipid particles composition - WP3601
- Liver X receptor pathway - WP2874
- Liver steatosis adverse outcome pathway - WP4010
- Lung fibrosis - WP3624
- Lung pathology of COVID-19 - WP5146
- MAP3K1 role in promoting and blocking gonadal determination - WP4872
- MAPK and NFkB signaling pathways inhibited by Yersinia YopJ - WP3849
- MAPK cascade - WP422
- MAPK pathway in congenital thyroid cancer - WP4928
- MAPK signaling pathway - WP382
- MECP2 and associated Rett syndrome - WP3584
- MET in type 1 papillary renal cell carcinoma - WP4205
- MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement - WP4560
- MFAP5-mediated ovarian cancer cell motility and invasiveness - WP3301
- MTHFR deficiency - WP4288
- MYD88 distinct input-output pathway - WP3877
- Macrophage markers - WP4146
- Macrophage-stimulating protein (MSP) signaling - WP5353
- Major receptors targeted by epinephrine and norepinephrine - WP4589
- Male infertility - WP4673
- Male steroid hormones in cardiomyocyte energy metabolism - WP5320
- Mammalian disorder of sexual development - WP4842
- Mammary gland development pathway - Embryonic development (Stage 1 of 4) - WP2813
- Mammary gland development pathway - Involution (Stage 4 of 4) - WP2815
- Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) - WP2817
- Mammary gland development pathway - Puberty (Stage 2 of 4) - WP2814
- Markers of kidney cell lineage - WP5236
- Matrix metalloproteinases - WP129
- Measles virus infection - WP4630
- Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms - WP4534
- Melanoma - WP4685
- Melatonin metabolism and effects - WP3298
- Mesodermal commitment pathway - WP2857
- Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia - WP5105
- Metabolic epileptic disorders - WP5355
- Metabolic pathway of LDL, HDL and TG, including diseases - WP4522
- Metabolic pathways of fibroblasts - WP5312
- Metabolic reprogramming in colon cancer - WP4290
- Metabolic reprogramming in pancreatic cancer - WP5220
- Metabolism of alpha-linolenic acid - WP4586
- Metabolism of dichloroethylene by CYP450 - WP3666
- Metabolism of sphingolipids in ER and Golgi apparatus - WP4142
- Metabolism of tetrahydrocannabinol (THC) - WP4174
- Metabolism overview - WP3602
- Metapathway biotransformation Phase I and II - WP702
- Metastatic brain tumor - WP2249
- Methionine de novo and salvage pathway - WP3580
- Methionine metabolism leading to sulfur amino acids and related disorders - WP4292
- Methylation pathways - WP704
- Mevalonate arm of cholesterol biosynthesis pathway - WP4190
- Mevalonate arm of cholesterol biosynthesis pathway with inhibitors - WP4189
- Mevalonate pathway - WP3963
- MicroRNA for targeting cancer growth and vascularization in glioblastoma - WP3593
- MicroRNA network associated with chronic lymphocytic leukemia - WP4399
- MicroRNAs in cardiomyocyte hypertrophy - WP1544
- Microglia pathogen phagocytosis pathway - WP3937
- Microtubule cytoskeleton regulation - WP2038
- Mineralocorticoid biosynthesis - WP5279
- Mitochondrial beta-oxidation - WP5241
- Mitochondrial complex I assembly model OXPHOS system - WP4324
- Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome - WP4944
- Mitochondrial complex I inhibition leading to parkinsonian motor deficits - WP4945
- Mitochondrial complex II assembly - WP4920
- Mitochondrial complex III assembly - WP4921
- Mitochondrial complex IV assembly - WP4922
- Mitochondrial complex inhibition leading to liver injury - WP5034
- Mitochondrial fatty acid oxidation disorders - WP5123
- Mitochondrial fatty acid synthesis pathway - WP4317
- Mitochondrial gene expression - WP391
- Mitochondrial immune response to SARS-CoV-2 - WP5038
- Mitochondrial long chain fatty acid beta-oxidation - WP368
- Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors - WP4397
- Modified nucleosides derived from tRNA as urinary cancer markers - WP4485
- Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids - WP5192
- Modulators of TCR signaling and T cell activation - WP5072
- Molybdenum cofactor (Moco) biosynthesis - WP4507
- Monoamine GPCRs - WP58
- Monoamine transport - WP727
- Multiple epiphyseal dysplasia and pseudoachondroplasia genes - WP4789
- Myometrial relaxation and contraction pathways - WP289
- N-glycan biosynthesis - WP5153
- NAD biosynthesis II (from tryptophan) - WP2485
- NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence - WP5046
- NAD metabolism, sirtuins and aging - WP3630
- NAD+ biosynthetic pathways - WP3645
- NAD+ metabolism - WP3644
- NF1 copy number variation syndrome - WP5366
- NIPBL role in DNA damage - Cornelia de Lange syndrome - WP5119
- NO/cGMP/PKG mediated neuroprotection - WP4008
- NOTCH1 regulation of endothelial cell calcification - WP3413
- NPHP1 deletion syndrome - WP5399
- NRF2 pathway - WP2884
- NRF2-ARE regulation - WP4357
- NRP1-triggered signaling pathways in pancreatic cancer - WP5144
- NRXN1 deletion syndrome - WP5398
- Nanomaterial induced apoptosis - WP2507
- Nanomaterial-induced inflammasome activation - WP3890
- Nanoparticle triggered autophagic cell death - WP2509
- Nanoparticle triggered regulated necrosis - WP2513
- Nanoparticle-mediated activation of receptor signaling - WP2643
- Neolacto series sphingolipid metabolism - WP5302
- Neovascularization processes - WP4331
- Nephrogenesis - WP5052
- Nephrotic syndrome - WP4758
- Nephrotoxcicity adverse outcome pathway - WP5229
- Netrin-UNC5B signaling pathway - WP4747
- Network map of SARS-CoV-2 signaling pathway - WP5115
- Neural crest cell migration during development - WP4564
- Neural crest cell migration in cancer - WP4565
- Neural crest differentiation - WP2064
- Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway - WP4577
- Neurogenesis regulation in the olfactory epithelium - WP5265
- Neuroinflammation - WP4919
- Neuroinflammation and glutamatergic signaling - WP5083
- Neurotransmitter disorders - WP4220
- Nicotine effect on chromaffin cells - WP1603
- Nicotine effect on dopaminergic neurons - WP1602
- Nicotine metabolism in liver cells - WP1600
- Nitric oxide metabolism in cystic fibrosis - WP4947
- Nod-like receptor (NLR) signaling pathway - WP288
- Non-classical role of vitamin D - WP5133
- Non-genomic actions of 1,25 dihydroxyvitamin D3 - WP4341
- Non-homologous end joining - WP438
- Non-small cell lung cancer - WP4255
- Nonalcoholic fatty liver disease - WP4396
- Notch signaling - WP268
- Notch signaling pathway - WP61
- Novel intracellular components of RIG-I-like receptor pathway - WP3865
- Nuclear receptors - WP170
- Nuclear receptors in lipid metabolism and toxicity - WP299
- Nuclear receptors meta-pathway - WP2882
- Nucleotide GPCRs - WP80
- Nucleotide excision repair - WP4753
- Nucleotide excision repair in xeroderma pigmentosum - WP5114
- Nucleotide-binding oligomerization domain (NOD) pathway - WP1433
- OSX and miRNAs in tooth development - WP3971
- Octadecanoid formation from linoleic acid - WP5324
- Oligodendrocyte specification and differentiation, leading to myelin components for CNS - WP4304
- Omega-3 / omega-6 fatty acid synthesis - WP4723
- Omega-6-fatty acids in senescence - WP5424
- Omega-9 fatty acid synthesis - WP4724
- Oncostatin M signaling pathway - WP2374
- One-carbon metabolism - WP241
- One-carbon metabolism and related pathways - WP3940
- Ophthalmate biosynthesis in hepatocytes - WP4487
- Opioid receptor pathways - WP5093
- Orexin receptor pathway - WP5094
- Osteoarthritic chondrocyte hypertrophy - WP5373
- Osteoblast differentiation and related diseases - WP4787
- Osteoblast signaling - WP322
- Osteoclast signaling - WP12
- Osteopontin signaling - WP1434
- Ovarian infertility - WP34
- Overlap between signal transduction pathways contributing to LMNA laminopathies - WP4879
- Overview of interferons-mediated signaling pathway - WP4558
- Overview of nanoparticle effects - WP3287
- Overview of proinflammatory and profibrotic mediators - WP5095
- Oxidation by cytochrome P450 - WP43
- Oxidative damage response - WP3941
- Oxidative phosphorylation - WP623
- Oxidative stress response - WP408
- Oxysterols derived from cholesterol - WP4545
- Oxytocin signaling - WP2889
- PAFAH1B1 copy number variation - WP5409
- PCSK9-mediated LDL receptor degradation - WP2846
- PDGF pathway - WP2526
- PDGFR-beta pathway - WP3972
- PGK1, PKM2, KHKC/KHKA acting as protein kinases - WP5433
- PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer - WP3844
- PI3K-Akt signaling pathway - WP4172
- PI3K/AKT/mTOR - vitamin D3 signaling - WP4141
- PKC-gamma calcium signaling pathway in ataxia - WP4760
- PPAR signaling pathway - WP3942
- PPAR-alpha pathway - WP2878
- PTF1A related regulatory pathway - WP4147
- Pancreatic adenocarcinoma pathway - WP4263
- Pancreatic cancer subtypes - WP5390
- Parkin-ubiquitin proteasomal system pathway - WP2359
- Parkinson's disease pathway - WP2371
- Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex - WP4884
- Pathogenic Escherichia coli infection - WP2272
- Pathophysiological roles of DUX4 in FSHD1 - WP5342
- Pathways affected in adenoid cystic carcinoma - WP3651
- Pathways of nucleic acid metabolism and innate immune sensing - WP4705
- Pentose phosphate metabolism - WP134
- Pentose phosphate pathway in senescent cells - WP5043
- Peptide GPCRs - WP24
- Peroxiredoxin 2 induced ovarian failure - WP4873
- Peroxisomal beta-oxidation of tetracosanoyl-CoA - WP1941
- Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins - WP4936
- Phase I biotransformations, non-P450 - WP136
- Phosphatidyl inositol phosphate pathway - WP5411
- Phosphatidylcholine catabolism - WP4195
- Phosphodiesterases in neuronal function - WP4222
- Phosphoinositides metabolism - WP4971
- Photodynamic therapy-induced AP-1 survival signaling - WP3611
- Photodynamic therapy-induced HIF-1 survival signaling - WP3614
- Photodynamic therapy-induced NF-kB survival signaling - WP3617
- Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling - WP3612
- Photodynamic therapy-induced unfolded protein response - WP3613
- Physico-chemical features and toxicity-associated pathways - WP3680
- Physiological and pathological hypertrophy of the heart - WP1528
- Pilocytic astrocytoma - WP2253
- Platelet-mediated interactions with vascular and circulating cells - WP4462
- Pleural mesothelioma - WP5087
- Pluripotent stem cell differentiation pathway - WP2848
- Polycystic kidney disease pathway - WP2571
- Polyol pathway - WP690
- Prader-Willi and Angelman syndrome - WP3998
- Pre-implantation embryo - WP3527
- Pregnane X receptor pathway - WP2876
- Primary focal segmental glomerulosclerosis (FSGS) - WP2572
- Primary ovarian insufficiency - WP5316
- Prion disease pathway - WP3995
- Pro-survival signaling of neuroprotectin D1 - WP5182
- Progeria-associated lipodystrophy - WP5103
- Prolactin signaling pathway - WP2037
- Proline and hydroxyproline pathways - WP5026
- Prostaglandin and leukotriene metabolism in senescence - WP5122
- Prostaglandin and leukotriene metabolism in senescence - WP5321
- Prostaglandin signaling - WP5088
- Prostaglandin synthesis and regulation - WP98
- Proteasome degradation - WP183
- Protein alkylation leading to liver fibrosis - WP3980
- Proteoglycan biosynthesis - WP4784
- Proximal tubule transport - WP4917
- PtdIns(4,5)P2 in cytokinesis pathway - WP5199
- Purine metabolism - WP4792
- Purine metabolism and related disorders - WP4224
- Purinergic signaling - WP4900
- Pyrimidine metabolism - WP4022
- Pyrimidine metabolism and related diseases - WP4225
- Quercetin and Nf-kB / AP-1 induced apoptosis - WP2435
- RAC1/PAK1/p38/MMP2 pathway - WP3303
- RANKL/RANK signaling pathway - WP2018
- RAS and bradykinin pathways in COVID-19 - WP4969
- RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis - WP3873
- ROS in COVID-19 endothelial dysfunction - WP5258
- RalA downstream regulated genes - WP2290
- Ras signaling - WP4223
- Regucalcin in proximal tubule epithelial kidney cells - WP4838
- Regulation of Wnt / B-catenin signaling by small molecule compounds - WP3664
- Regulation of actin cytoskeleton - WP51
- Regulation of apoptosis by parathyroid hormone-related protein - WP3872
- Regulation of sister chromatid separation at the metaphase-anaphase transition - WP4240
- Regulatory circuits of the STAT3 signaling pathway - WP4538
- Relationship between inflammation, COX-2 and EGFR - WP4483
- Renin-angiotensin-aldosterone system (RAAS) - WP4756
- Resistin as a regulator of inflammation - WP4481
- Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution - WP5191
- Retinoblastoma gene in cancer - WP2446
- Retinol metabolism - WP5188
- Rett syndrome - WP4312
- Riboflavin and CoQ disorders - WP5037
- Robo4 and VEGF signaling pathways crosstalk - WP3943
- Role of carnosine in muscle contraction - WP4486
- Roles of ceramides in development of insulin resistance - WP5181
- Rubinstein-Taybi syndrome 1 - WP5367
- S1P receptor signal transduction - WP26
- SARS coronavirus and innate immunity - WP4912
- SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation - WP5116
- SARS-CoV-2 altering angiogenesis via NRP1 - WP5065
- SARS-CoV-2 and ACE2 receptor: molecular mechanisms - WP4883
- SARS-CoV-2 and COVID-19 pathway - WP4846
- SARS-CoV-2 innate immunity evasion and cell-specific immune response - WP5039
- SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction - WP5183
- SARS-CoV-2 replication organelle formation - WP5156
- SCFA and skeletal muscle substrate metabolism - WP4030
- SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome - WP5118
- SREBF and miR33 in cholesterol and lipid homeostasis - WP2011
- SRF and miRs in smooth muscle differentiation and proliferation - WP1991
- STING pathway in Kawasaki-like disease and COVID-19 - WP4961
- Sebaleic acid formation and metabolism - WP5315
- Secretion of hydrochloric acid in parietal cells - WP2597
- Selective expression of chemokine receptors during T-cell polarization - WP4494
- Selenium metabolism and selenoproteins - WP28
- Selenium micronutrient network - WP15
- Serine metabolism - WP4688
- Serotonin HTR1 group and FOS pathway - WP722
- Serotonin and anxiety - WP3947
- Serotonin and anxiety-related events - WP3944
- Serotonin receptor 2 and ELK-SRF/GATA4 signaling - WP732
- Serotonin receptor 4/6/7 and NR3C signaling - WP734
- Serotonin transporter activity - WP1455
- Sialylation - WP5151
- Signal transduction through IL1R - WP4496
- Sildenafil treatment - WP5294
- Sleep regulation - WP3591
- Small cell lung cancer - WP4658
- Small ligand GPCRs - WP247
- Smith-Magenis and Potocki-Lupski syndrome copy number variation - WP5381
- Soluble ACE2-mediated cell entry of SARS-CoV-2 - WP5076
- Somatic sex determination - WP4814
- Somatroph axis (GH) and its relationship to dietary restriction and aging - WP4186
- Somitogenesis in the context of spondylocostal dysostosis - WP4785
- Sphingolipid metabolism in senescence - WP5121
- Sphingolipid metabolism overview - WP4725
- Sphingolipid metabolism: integrated pathway - WP4726
- Sphingolipid pathway - WP1422
- Spina bifida - WP5150
- Spinal cord injury - WP2431
- Splicing factor NOVA regulated synaptic proteins - WP4148
- Statin inhibition of cholesterol production - WP430
- Steroid biosynthesis - WP496
- Steroid hormone precursor biosynthesis - WP5277
- Sterol regulatory element-binding proteins (SREBP) signaling - WP1982
- Striated muscle contraction pathway - WP383
- Sudden infant death syndrome (SIDS) susceptibility pathways - WP706
- Sulfatase and aromatase pathway - WP5368
- Sulfation biotransformation reaction - WP692
- Sulindac metabolic pathway - WP2542
- Suppression of HMGB1-mediated inflammation by THBD - WP4479
- Synaptic signaling pathways associated with autism spectrum disorder - WP4539
- Synaptic vesicle pathway - WP2267
- Synthesis of ceramides and 1-deoxyceramides - WP5194
- T cell modulation in pancreatic cancer - WP5078
- T cell receptor and co-stimulatory signaling - WP2583
- T-cell activation SARS-CoV-2 - WP5098
- T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection - WP3863
- T-cell receptor signaling pathway - WP69
- TAR syndrome - WP5362
- TCA cycle (aka Krebs or citric acid cycle) - WP78
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP2453
- TCA cycle in senescence - WP5050
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP2868
- TGF-beta receptor signaling - WP560
- TGF-beta receptor signaling in skeletal dysplasias - WP4816
- TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition - WP3859
- TGF-beta signaling pathway - WP366
- TGFβ/Smad signaling pathway - WP5382
- TLR4 signaling and tolerance - WP3851
- TNF-alpha signaling pathway - WP231
- TNF-related weak inducer of apoptosis (TWEAK) signaling pathway - WP2036
- TP53 network - WP1742
- TROP2 regulatory signaling - WP5300
- TYROBP causal network in microglia - WP3945
- Tamoxifen metabolism - WP691
- Target of rapamycin signaling - WP1471
- Tgif disruption of Shh signaling - WP3674
- Th17 cell differentiation pathway - WP5130
- Thermogenesis - WP4321
- Thiamine metabolic pathways - WP4297
- Thymic stromal lymphopoietin (TSLP) signaling pathway - WP2203
- Thyroid hormone imbalance leading to neurodevelopmental abnormalities - WP5227
- Thyroid hormones production and peripheral downstream signaling effects - WP4746
- Thyroid stimulating hormone (TSH) signaling pathway - WP2032
- Thyroxine (thyroid hormone) production - WP1981
- Toll-like receptor signaling pathway - WP75
- Toll-like receptor signaling related to MyD88 - WP3858
- Trans-sulfuration pathway - WP2333
- Trans-sulfuration, one-carbon metabolism and related pathways - WP2525
- Transcription co-factors SKI and SKIL protein partners - WP4533
- Transcription factor regulation in adipogenesis - WP3599
- Transcription factors regulate miRNAs related to cardiac hypertrophy - WP1559
- Transcriptional activation by NRF2 in response to phytochemicals - WP3
- Transcriptional cascade regulating adipogenesis - WP4211
- Translation factors - WP107
- Translation inhibitors in chronically activated PDGFRA cells - WP4566
- Triacylglyceride synthesis - WP325
- Tryptophan catabolism leading to NAD+ production - WP4210
- Tryptophan metabolism - WP465
- Tumor suppressor activity of SMARCB1 - WP4204
- Type 2 papillary renal cell carcinoma - WP4241
- Type I collagen synthesis in the context of osteogenesis imperfecta - WP4786
- Type I interferon induction and signaling during SARS-CoV-2 infection - WP4868
- Type II diabetes mellitus - WP1584
- Type II interferon signaling - WP619
- Type III interferon signaling - WP2113
- Tyrosine metabolism and related disorders - WP4506
- UDP-derived sugars synthesis in fibroblasts - WP5394
- Ulcerative colitis signaling - WP5174
- Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer - WP4284
- Unfolded protein response - WP4925
- Urea cycle and associated pathways - WP4595
- Urea cycle and metabolism of amino groups - WP497
- Urea cycle and related diseases - WP4571
- Urotensin-II-mediated signaling pathway - WP5158
- VEGFA-VEGFR2 signaling - WP3888
- Valproic acid pathway - WP3871
- Vasopressin-regulated water reabsorption - WP5085
- Vitamin A and carotenoid metabolism - WP716
- Vitamin A1 and A5/X pathways - WP5397
- Vitamin B12 disorders - WP4271
- Vitamin B12 metabolism - WP1533
- Vitamin B6-dependent and responsive disorders - WP4228
- Vitamin D in inflammatory diseases - WP4482
- Vitamin D metabolism - WP1531
- Vitamin D receptor pathway - WP2877
- Vitamin D-sensitive calcium signaling in depression - WP4698
- Vitamin K metabolism and activation of dependent proteins - WP5186
- Vitamins A and D - action mechanisms - WP4342
- Warburg effect modulated by deubiquitinating enzymes and their substrates - WP5216
- White fat cell differentiation - WP4149
- Wnt signaling - WP428
- Wnt signaling in kidney disease - WP4150
- Wnt signaling pathway - WP363
- Wnt signaling pathway and pluripotency - WP399
- Wnt/Beta-catenin signaling inhibitors in current and past clinical trials - WP5442
- Wnt/beta-catenin signaling pathway in leukemia - WP3658
- Zinc homeostasis - WP3529
- eIF5A regulation in response to inhibition of the nuclear export system - WP3302
- exRNA mechanism of action and biogenesis - WP2805
- let-7 inhibition of ES cell reprogramming - WP3299
- lncRNA in canonical Wnt signaling and colorectal cancer - WP4258
- lncRNA-mediated mechanisms of therapeutic resistance - WP3672
- mBDNF and proBDNF regulation of GABA neurotransmission - WP4829
- mRNA processing - WP411
- mRNA vaccine activation of dendritic cell and induction of IFN-1 - WP5187
- mRNA, protein, and metabolite inducation pathway by cyclosporin A - WP3953
- miR-222 in exercise-induced cardiac growth - WP3938
- miR-509-3p alteration of YAP1/ECM axis - WP3967
- miR-517 relationship with ARCN1 and USP1 - WP3596
- miRNA biogenesis - WP2338
- miRNA degrading enzymes - WP4316
- miRNA regulation of DNA damage response - WP1530
- miRNA regulation of p53 pathway in prostate cancer - WP3982
- miRNA regulation of prostate cancer signaling pathways - WP3981
- miRNA role in immune response in sepsis - WP4329
- miRNA targets in ECM and membrane receptors - WP2911
- miRNAs involved in DNA damage response - WP1545
- mir-124 predicted interactions with cell cycle and differentiation - WP3595
- ncRNAs involved in STAT3 signaling in hepatocellular carcinoma - WP4337
- ncRNAs involved in Wnt signaling in hepatocellular carcinoma - WP4336
- nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell - WP5027
- p38 MAPK signaling pathway - WP400
- p53 transcriptional gene network - WP4963